نتایج جستجو برای: onset type (eoad)

تعداد نتایج: 1494578  

Journal: :iranian journal of public health 0
mohammad khanahmadi dept. of clinical psychology, allame tabataba’i university, tehran, iran. dariush d.farhud d.farhud school of public health, tehran university of medical sciences, tehran, iran and dept. of basic sciences, iranian academy of medical sciences, tehran, iran. maryam malmir dept. of exceptional children psychology, science & research branch, islamic azad university, tehran, iran.

background : alzheimer's disease (ad) is one of the most common problems for old peoples. etiology of ad is not clear, but genetic factors play a major role in determining a person's risk to develop ad. twin and family studies con-firm that ad has a genetic basis.ad genetics has been split into two broad categories: early-onset and late-onset. eo-ad cases are inherited in an autosomal dominant ...

2004
Cornelia M. van Duijn Juliana B. Bronzova Albert Hofman Christine Van Broeckhoven

It was suggested that in contrast to the E4 allele, the E2 allele of the apolipoprotein E gene (APOE"2) has a protective effect for late-onset Alzheimer's disease and early-onset Alzheimer's disease (EOAD). We studied the role of the APOE*2 allele in the pathogenesis of EOAD in a Dutch population-based study of 175 probable EOAD patients with onset age at or before 65 years and 532 age-matched ...

Journal: :Human molecular genetics 2000
J Theuns J Del-Favero B Dermaut C M van Duijn H Backhovens M V Van den Broeck S Serneels E Corsmit C V Van Broeckhoven M Cruts

Mutations in the presenilin 1 ( PSEN1 ) gene have been implicated in 18-50% of autosomal dominant cases with early-onset Alzheimer's disease (EOAD). Also, PSEN1 has been suggested as a potential risk gene in late-onset AD cases. We recently showed genetic association in a population-based study of EOAD, pointing to the 5' regulatory region of PSEN1. In this study we systematically screened 3.5 ...

Journal: :Archives of neurology 2012
Thomas S Wingo James J Lah Allan I Levey David J Cutler

OBJECTIVES To determine the genetic contribution to non-autosomal dominant early-onset Alzheimer disease (EOAD) (onset age ≤60 years) cases and identify the likely mechanism of inheritance in those cases. DESIGN A liability threshold model of disease was used to estimate heritability of EOAD and late-onset Alzheimer disease (AD) using concordance for AD among parent-offspring pairs. SETTING...

2012
Astrid M. Hooghiemstra Laura H.P. Eggermont Philip Scheltens Wiesje M. van der Flier Erik J.A. Scherder

BACKGROUND/AIMS Although studies show a negative relationship between physical activity and the risk for cognitive impairment and late-onset Alzheimer's disease, studies concerning early-onset Alzheimer's disease (EOAD) are lacking. This review aims to justify the value of exercise interventions in EOAD by providing theoretical considerations that include neurobiological processes. METHODS A ...

2017
Young Chul Youn Jae-Won Jang Su-Hyun Han HyeRyoun Kim Ju-Won Seok Jun Soo Byun Kwang-Yeol Park Seong Soo A An In Kook Chun SangYun Kim

PURPOSE Early-onset Alzheimer's disease (EOAD) has a different pathologic burden and clinical features compared with late-onset Alzheimer's disease (LOAD). We examined the effects of age at onset on the burden and distribution of β-amyloid in patients with EOAD, in whom well-characterized mutations associated with Alzheimer's disease were absent. METHODS We genotyped ApoE, APP, PSEN1 and PSEN...

2013
Fanny Rubio-Moscardo Núria Setó-Salvia Marta Pera Mònica Bosch-Morató Cristina Plata Olivia Belbin Gemma Gené Oriol Dols-Icardo Martin Ingelsson Seppo Helisalmi Hilkka Soininen Mikko Hiltunen Vilmantas Giedraitis Lars Lannfelt Ana Frank MªJesús Bullido Onofre Combarros Pascual Sánchez-Juan Mercè Boada Lluís Tárraga Pau Pastor Jordi Pérez-Tur Miquel Baquero José L. Molinuevo Raquel Sánchez-Valle Pablo Fuentes-Prior Juan Fortea Rafael Blesa Francisco J. Muñoz Alberto Lleó Miguel A. Valverde Jordi Clarimón

Calcium signaling in the brain is fundamental to the learning and memory process and there is evidence to suggest that its dysfunction is involved in the pathological pathways underlying Alzheimer's disease (AD). Recently, the calcium hypothesis of AD has received support with the identification of the non-selective Ca(2+)-permeable channel CALHM1. A genetic polymorphism (p. P86L) in CALHM1 red...

2016
Seong Soo An Sun Ah Park Eva Bagyinszky Sun Oh Bae Yoon-Jeong Kim Ji Young Im Kyung Won Park Kee Hyung Park Eun-Joo Kim Jee Hyang Jeong Jong Hun Kim Hyun Jeong Han Seong Hye Choi SangYun Kim

Early-onset Alzheimer's disease (EOAD) has distinct clinical characteristics in comparison to late-onset Alzheimer's disease (LOAD). The genetic contribution is suggested to be more potent in EOAD. However, the frequency of causative mutations in EOAD could be variable depending on studies. Moreover, no mutation screening study has been performed yet employing large population in Korea. Previou...

2015
Rita Cacace Tobi Van den Bossche Sebastiaan Engelborghs Nathalie Geerts Annelies Laureys Lubina Dillen Caroline Graff Håkan Thonberg Huei‐Hsin Chiang Pau Pastor Sara Ortega‐Cubero Maria A. Pastor Janine Diehl‐Schmid Panagiotis Alexopoulos Luisa Benussi Roberta Ghidoni Giuliano Binetti Benedetta Nacmias Sandro Sorbi Raquel Sanchez‐Valle Albert Lladó Ellen Gelpi Maria Rosário Almeida Isabel Santana Magda Tsolaki Maria Koutroumani Jordi Clarimon Alberto Lleó Juan Fortea Alexandre de Mendonça Madalena Martins Barbara Borroni Alessandro Padovani Radoslav Matej Zdenek Rohan Mathieu Vandenbulcke Rik Vandenberghe Peter P. De Deyn Patrick Cras Julie van der Zee Kristel Sleegers Christine Van Broeckhoven

Rare variants in the phospholipase D3 gene (PLD3) were associated with increased risk for late-onset Alzheimer disease (LOAD). We identified a missense mutation in PLD3 in whole-genome sequence data of a patient with autopsy confirmed Alzheimer disease (AD) and onset age of 50 years. Subsequently, we sequenced PLD3 in a Belgian early-onset Alzheimer disease (EOAD) patient (N = 261) and control ...

2017
Carina Wattmo Åsa K. Wallin

BACKGROUND/AIMS Whether age at onset influences functional deterioration in Alzheimer disease (AD) is unclear. We, therefore, investigated risk factors for progression in activities of daily living (ADL) and nursing home placement (NHP) in cholinesterase inhibitor (ChEI)-treated patients with early-onset AD (EOAD) versus late-onset AD (LOAD). METHODS This 3-year, prospective, observational, m...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید